UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049353
Receipt number R000056200
Scientific Title Monitoring examination of the lifestyle-related disease prevention
Date of disclosure of the study information 2023/01/31
Last modified on 2022/10/27 21:25:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Monitoring examination of the lifestyle-related disease prevention

Acronym

Monitoring examination of the lifestyle-related disease prevention

Scientific Title

Monitoring examination of the lifestyle-related disease prevention

Scientific Title:Acronym

Monitoring examination of the lifestyle-related disease prevention

Region

Japan


Condition

Condition

Lifestyle-related disease prevention

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Self-administration of the lifestyle-related disease prevention

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Urinalysis and blood test

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Volunteer

Key exclusion criteria

Illness person

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Kanazawa

Organization

First Screening Corp.

Division name

Board

Zip code

151-0053

Address

1-30-14 Yoyogi Shibuya Tokyo

TEL

050-3631-7556

Email

kanazawa@first-screening.com


Public contact

Name of contact person

1st name Tetsuro
Middle name
Last name Ieda

Organization

Board

Division name

Board

Zip code

151-0053

Address

1-30-14 Yoyogi Shibuya Tokyo

TEL

050-3631-7556

Homepage URL


Email

ieda@first-screening.com


Sponsor or person

Institute

First Screening Corp.

Institute

Department

Personal name



Funding Source

Organization

First Screening Corp.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

SOUKEN

Address

1-9-10 Hamamatsu-Cho, Minatoku, Tokyo

Tel

050-3390-9275

Email

y_huzita@mail.souken-r.com


Secondary IDs

Secondary IDs

YES

Study ID_1

150418_rn-33368

Org. issuing International ID_1

Shiba Palace Clinic

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

200

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 08 Month 31 Day

Date of IRB

2022 Year 09 Month 01 Day

Anticipated trial start date

2022 Year 09 Month 01 Day

Last follow-up date

2023 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Urinalysis and blood test


Management information

Registered date

2022 Year 10 Month 28 Day

Last modified on

2022 Year 10 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056200


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name